Skip to main content
. 2009 Mar 10;9:52. doi: 10.1186/1471-2180-9-52

Table 1.

Production of TSST-1 evaluated by Western blotting.

No. Strain μg/ml No. Strain μg/ml
1 N315 3.5 ± 0.22 18 2680 1.4 ± 0.19
2 A36 14 ± 1.01 19 2681 1.3 ± 0.05
3 3429 5 ± 0.12 20 2682 1.0 ± 0.25
4 3472 1.3 ± 0.31 21 2683 1.0 ± 0.01
5 3337 1.1 ± 0.20 22 2684 0.8 ± 0.02
6 1785 1.2 ± 0.02 23 2685 1.6 ± 0.23
7 2271 2.0 ± 0.03 24 2686 2.0 ± 0.18
8 3281 4.0 ± 0.22 25 2687 1.6 ± 0.22
9 2932 2.8 ± 0.19 26 2688 7.6 ± 0.07
10 3543 14 ± 1.21 27 2689 9.8 ± 0.28
11 3573 12 ± 0.20 28 2690 3.1 ± 0.16
12 V432 7.0 ± 0.25 29 2701 5.0 ± 1.12
13 V637 7.6 ± 0.30 30 2702 2.8 ± 0.23
14 V666 5.2 ± 0.11 31 2165 4.0 ± 0.13
15 V700 8.0 ± 0.21 32 3624 1.0 ± 0.19
16 V723 1.3 ± 0.34 33 3878 2.2 ± 0.20
17 V694 4.0 ± 0.22 34 3890 6.4 ± 0.08

Strain 1, genome strain. Strains 2 to 34 were randomly selected clinical MRSA isolates that were all tst-positive and assigned to agr class 2 by PCR. Amounts of TSST-1 varied among strains and ranged from 0.8 to 14 μg/ml.